Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Mankind Pharma Yönetim
Yönetim kriter kontrolleri 3/4
Mankind Pharma's CEO is Sheetal Arora, appointed in Jan 2021, has a tenure of 3.75 years. total yearly compensation is ₹154.13M, comprised of 32.7% salary and 67.3% bonuses, including company stock and options. directly owns 5.55% of the company’s shares, worth ₹57.34B. The average tenure of the management team and the board of directors is 3.8 years and 8.1 years respectively.
Anahtar bilgiler
Sheetal Arora
İcra Kurulu Başkanı
₹154.1m
Toplam tazminat
| CEO maaş yüzdesi | 32.7% |
| CEO görev süresi | 3.8yrs |
| CEO sahipliği | 5.5% |
| Yönetim ortalama görev süresi | 3.8yrs |
| Yönetim Kurulu ortalama görev süresi | 8.1yrs |
Son yönetim güncellemeleri
Recent updates
Here's Why Mankind Pharma (NSE:MANKIND) Can Manage Its Debt Responsibly
Aug 26
Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)
Jul 12Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors
May 08Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't
Apr 08Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 04CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹20b |
| Mar 31 2024 | ₹154m | ₹50m | ₹19b |
| Dec 31 2023 | n/a | n/a | ₹17b |
| Sep 30 2023 | n/a | n/a | ₹16b |
| Jun 30 2023 | n/a | n/a | ₹15b |
| Mar 31 2023 | ₹155m | ₹50m | ₹13b |
| Dec 31 2022 | n/a | n/a | ₹12b |
| Mar 31 2022 | ₹155m | ₹50m | ₹14b |
| Mar 31 2021 | ₹155m | n/a | ₹13b |
| Mar 31 2020 | ₹118m | n/a | ₹10b |
Tazminat ve Piyasa: Sheetal's total compensation ($USD1.84M) is above average for companies of similar size in the Indian market ($USD1.09M).
Tazminat ve Kazançlar: Sheetal's compensation has been consistent with company performance over the past year.
CEO
Sheetal Arora (49 yo)
3.8yrs
Görev süresi
₹154,125,000
Tazminat
Mr. Sheetal Arora served as Managing Director and Director at Mankind Pharma Limited until 2021 and also serves as its Chief Executive Officer since 2021. Mr. Arora served as Director of Marketing at Manki...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 18.5yrs | ₹267.89m | 25.15% ₹ 259.9b | |
| CEO & Whole-Time Director | 3.8yrs | ₹154.13m | 5.55% ₹ 57.3b | |
| Vice Chairman & MD | 31.8yrs | ₹289.05m | 25.75% ₹ 266.0b | |
| Whole-Time Director | no data | ₹9.34m | Veri yok | |
| Chief Financial Officer | 8.6yrs | ₹24.23m | Veri yok | |
| Chief Operating Officer | 3.6yrs | ₹57.86m | 2.04% ₹ 21.0b | |
| Director of Technology | 4.9yrs | ₹3.91m | 0.97% ₹ 10.0b | |
| President - Group Chief Information Officer | no data | ₹30.00m | Veri yok | |
| Chief Scientific Officer (Research Centre) | 12.8yrs | ₹46.12m | Veri yok | |
| Head of Investor Relations | no data | Veri yok | Veri yok | |
| Company Secretary & Compliance Officer | 8.1yrs | ₹4.97m | Veri yok | |
| Chief Marketing Officer | 3.6yrs | ₹35.00m | Veri yok |
3.8yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim: MANKIND's management team is considered experienced (3.8 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 18.5yrs | ₹267.89m | 25.15% ₹ 259.9b | |
| CEO & Whole-Time Director | 17.1yrs | ₹154.13m | 5.55% ₹ 57.3b | |
| Vice Chairman & MD | 31.8yrs | ₹289.05m | 25.75% ₹ 266.0b | |
| Whole-Time Director | 8.1yrs | ₹9.34m | Veri yok | |
| Independent Director | 2.2yrs | ₹3.02m | Veri yok | |
| Independent Director | 4.8yrs | ₹3.80m | Veri yok | |
| Independent Director | 6.2yrs | ₹2.28m | Veri yok | |
| Independent Director | 2.2yrs | ₹3.40m | Veri yok | |
| Independent Director | 9.7yrs | ₹2.84m | Veri yok |
8.1yrs
Ortalama Görev Süresi
60yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: MANKIND's board of directors are considered experienced (8.1 years average tenure).